Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoshihiro Konno
Observed names:
Y Konno,
Y. Konno
Institution:
Taisho Pharmaceutical (Japan)
Observed institutions:
Setsunan University,
Shizuoka University,
Taisho Pharmaceutical (Japan),
University of Shizuoka,
Kaken Pharmaceutical (Japan)
ORCID:
0009-0005-7936-5890
Observed ORCID:
0009-0005-7936-5890
OpenAlex ID:
A5102762778
Assessment of Intestinal Availability of Various Drugs in the Oral Absorption Process Using Portal Vein-Cannulated Rats
2012
·
Yoshiki Matsuda
, Yoshihiro Konno
, et al.
·
Drug Metabolism and Disposition
·
49
Multiparametric assay using HepaRG cells for predicting drug-induced liver injury
2015
·
Takafumi Tomida
, Hayao Okamura
, et al.
·
Toxicology Letters
·
40
Quantitative Assessment of Intestinal First-pass Metabolism of Oral Drugs Using Portal-vein Cannulated Rats
2014
·
Yoshiki Matsuda
, Yoshihiro Konno
, et al.
·
Pharmaceutical Research
·
28
Prediction of human percutaneous absorption from in vitro and in vivo animal experiments
2017
·
Hiromichi Yoshimatsu
, Kunikazu Ishii
, et al.
·
International Journal of Pharmaceutics
·
23
Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant/TS‐142 in healthy Japanese participants following single/multiple dosing: Randomized, double‐blind, placebo‐controlled phase‐1 studies
2023
·
Daiji Kambe
, Sayaka Hasegawa
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
21
PDF
A modified multiparametric assay using HepaRG cells for predicting the degree of drug‐induced liver injury risk
2016
·
Takafumi Tomida
, Hayao Okamura
, et al.
·
Journal of Applied Toxicology
·
19
Establishment of In Silico Prediction Models for CYP3A4 and CYP2B6 Induction in Human Hepatocytes by Multiple Regression Analysis Using Azole Compounds
2016
·
Mika Nagai
, Yoshihiro Konno
, et al.
·
Drug Metabolism and Disposition
·
16
Preclinical pharmacological profiles of vornorexant, a novel potent dual orexin receptor antagonist
2025
·
Hirohiko Hikichi
, Yuichi Tokumaru
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
12
PDF
Induction of hepatic cytochrome P450s responsible for the metabolism of xenobiotics by nicardipine and other calcium channel antagonists in the male rat
2003
·
Y. Konno
, K. Nemoto
, et al.
·
Xenobiotica
·
11
Preclinical metabolism and the disposition of vornorexant/TS‐142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomnia
2024
·
Yoshihiro Konno
, Shunsuke Kamigaso
, et al.
·
Pharmacology Research & Perspectives
·
10
Estimation of the Orexin Receptor Occupancy From Human Plasma Pharmacokinetics of Vornorexant, a Novel Dual Orexin 1/2 Receptor Antagonist for the Treatment of Insomnia
2026
·
Shunsuke Kamigaso
, Yoshihiro Konno
, et al.
·
Pharmacology Research & Perspectives
·
1
In vitro assessments for pharmacokinetic drug-drug interaction potential of vornorexant, a novel dual orexin 1/2 receptor antagonist
2026
·
Shunsuke Kamigaso
, Yoshihiro Konno
, et al.
·
Xenobiotica
0004 TS-142: A Novel and Potent Dual Orexin Receptor Antagonist with Sleep-Promoting Effects in Rats
2020
·
D Kambe
, H Hikichi
, et al.
·
SLEEP
Study on Adhesive Characteristics of Formulation Modified Esflurbiprofen Mentha Oil Formulation (SFP tape), a Transdermal Analgesic/Anti-inflammatory Tape
2020
·
Tsuyoshi Endo
, Junichi Sato
, et al.
·
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
PDF
Show more works
View as search
Works count:
14
Citation count:
230
H-index:
10
I10-index:
10
Year
Topic
Type
